Bempedoic acid
Esperion
[]
$espr nexletol scores in clear outcomes, but 13% reduction misses the most bullish expectations. via @ #acc23 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.